UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 478

Sortiert nach

Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis

Mayo Clinic proceedings, 2007, Vol.82 (3), p.364-380

2007

Volltextzugriff (PDF)

Malignant melanoma in the 21st century, Part 1: Epidemiology, risk factors, screening, prevention, and diagnosis

Mayo Clinic proceedings, 2007-03, Vol.82 (3), p.364-380

2007

Volltextzugriff (PDF)

Malignant Melanoma in the 21st Century, Part 2: Staging, Prognosis, and Treatment

Mayo Clinic proceedings, 2007-04, Vol.82 (4), p.490-513

2007

Volltextzugriff (PDF)

Disruption of Parallel and Converging Signaling Pathways Contributes to the Synergistic Antitumor Effects of Simultaneous mTOR and EGFR Inhibition in GBM Cells

Neoplasia (New York, N.Y.), 2005-10, Vol.7 (10), p.921-929

2005

Volltextzugriff (PDF)

Current Strategies in Treatment of Oligodendroglioma: Evolution of Molecular Signatures of Response

Journal of clinical oncology, 2006-03, Vol.24 (8), p.1246-1252

2006

Volltextzugriff (PDF)

Altered molecular pathways in gliomas: An overview of clinically relevant issues

Seminars in oncology, 2004-10, Vol.31 (5), p.595-604

2004

Volltextzugriff (PDF)

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy : A phase 3 randomized, double-blind, placebo-controlled, crossover trial (NOOC3)

Cancer, 2007-11, Vol.110 (9), p.2110-2118

2007

Volltextzugriff (PDF)

Efficacy of Lamotrigine in the Management of Chemotherapy-induced Peripheral Neuropathy : A Phase 3 Randomized, Double-blind, Placebo-controlled Trial, N01C3

Cancer, 2008-06, Vol.112 (12), p.2802-2808

2008

Volltextzugriff (PDF)

Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic

Neuro-oncology (Charlottesville, Va.), 2009-08, Vol.11 (4), p.437-445

2009

Volltextzugriff (PDF)

Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG‐N0377, Alliance)

The oncologist (Dayton, Ohio), 2018-08, Vol.23 (8), p.887-e94

2018

Volltextzugriff (PDF)

Combination of Temsirolimus (CCI-779) with Chemoradiation in Newly Diagnosed Glioblastoma Multiforme (GBM) (NCCTG trial N027D) Is Associated with Increased Infectious Risks

Clinical cancer research, 2010-11, Vol.16 (22), p.5573-5580

2010

Volltextzugriff (PDF)

The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: A surveillance, epidemiology, and End Results analysis

Cancer, 2002-10, Vol.95 (7), p.1504-1510

2002

Volltextzugriff (PDF)

Extremophiles: From Biology to Biotechnology

1, 2018

Volltextzugriff (PDF)

Combination of paclitaxel and carboplatin as second‐line therapy for patients with metastatic melanoma

Cancer, 2006-01, Vol.106 (2), p.375-382

2006

Volltextzugriff (PDF)

Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agents

Current cancer drug targets, 2004-12, Vol.4 (8), p.621

2004

Volltextzugriff (PDF)

Oncology: An Evidence-Based Approach

Mayo Clinic Proceedings, 2006-05, Vol.81 (5), p.706-706

Rao, Ravi D.

2006

Volltextzugriff (PDF)

Intratracheal Melanoma Metastases

The New England journal of medicine, 2006-09, Vol.355 (13), p.1357-1357

2006

Volltextzugriff (PDF)

Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization

American journal of clinical oncology, 2006-08, Vol.29 (4), p.352-360

2006

Volltextzugriff (PDF)

Melanoma-induced brain metastases

Expert review of anticancer therapy, 2008-05, Vol.8 (5), p.743-755

2008

Volltextzugriff (PDF)

Chemotherapy-induced neuropathy

Current oncology reports, 2007-07, Vol.9 (4), p.290-299

2007

Volltextzugriff (PDF)

Innovation in the management of brain metastases

Oncology (Williston Park, N.Y.), 2007-04, Vol.21 (4), p.473-81; discussion 482

2007

Volltextzugriff (PDF)

Risk of multiple primary melanomas

JAMA : the journal of the American Medical Association, 2006-04, Vol.295 (13), p.1516

2006

Volltextzugriff (PDF)

Efficacy of lamotrigine in the management of chemotherapy‐induced peripheral neuropathy

Cancer, 2008-06, Vol.112 (12), p.2802-2808

2008

Volltextzugriff (PDF)

Aerosolized granulocyte macrophage colony-stimulating factor (GM-CSF) therapy in metastatic cancer

American journal of clinical oncology, 2003-10, Vol.26 (5), p.493-498

2003

Volltextzugriff (PDF)

Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy

Cancer, 2007-11, Vol.110 (9), p.2110-2118

2007

Volltextzugriff (PDF)

1 – 25 von 478

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(339)
Mit Volltextzugriff
(418)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis

Malignant melanoma in the 21st century, Part 1: Epidemiology, risk factors, screening, prevention, and diagnosis

Malignant Melanoma in the 21st Century, Part 2: Staging, Prognosis, and Treatment

Disruption of Parallel and Converging Signaling Pathways Contributes to the Synergistic Antitumor Effects of Simultaneous mTOR and EGFR Inhibition in GBM Cells

Current Strategies in Treatment of Oligodendroglioma: Evolution of Molecular Signatures of Response

Altered molecular pathways in gliomas: An overview of clinically relevant issues

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy : A phase 3 randomized, double-blind, placebo-controlled, crossover trial (NOOC3)

Efficacy of Lamotrigine in the Management of Chemotherapy-induced Peripheral Neuropathy : A Phase 3 Randomized, Double-blind, Placebo-controlled Trial, N01C3

Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic

Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG‐N0377, Alliance)

Combination of Temsirolimus (CCI-779) with Chemoradiation in Newly Diagnosed Glioblastoma Multiforme (GBM) (NCCTG trial N027D) Is Associated with Increased Infectious Risks

The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: A surveillance, epidemiology, and End Results analysis

Extremophiles: From Biology to Biotechnology

Combination of paclitaxel and carboplatin as second‐line therapy for patients with metastatic melanoma

Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agents

Oncology: An Evidence-Based Approach

Intratracheal Melanoma Metastases

Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization

Melanoma-induced brain metastases

Chemotherapy-induced neuropathy

Innovation in the management of brain metastases

Risk of multiple primary melanomas

Efficacy of lamotrigine in the management of chemotherapy‐induced peripheral neuropathy

Aerosolized granulocyte macrophage colony-stimulating factor (GM-CSF) therapy in metastatic cancer

Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy

Suchergebnisse filtern